Does giritinib (segatan) need to be taken with food and what are the dietary precautions?

Gilitinib is an oral small molecule tyrosine kinase inhibitor (TKI), mainly used to treat patients with FLT3 mutation-positive relapsed or refractory acute myeloid leukemia (AML). Its drug absorption is relatively less affected by gastric acid and gastric emptying speed, so the clinical medication instructions do not strictly require that it must be taken with food. However, some patients may experience mild gastrointestinal discomfort, such as nausea or abdominal discomfort, due to taking the drug on an empty stomach.

In order to reduce gastrointestinal adverse reactions, clinical practice usually recommends that patients take giritinib with or after meals, which can effectively alleviate potential discomfort. Taking the drug with meals will not significantly affect its blood concentration and efficacy, so the medication time can be flexibly adjusted according to the patient's own tolerance. For patients with sensitive gastrointestinal tracts, especially in the initial stage of medication, it is usually more safe to take it with food.

In terms of diet, patients should be careful to avoid simultaneous intake of large amounts of foods and supplements that may affect drug absorption or metabolism. For example, foods containing a large amount of grapefruit or grapefruit juice may affect the metabolism of giritinib by inhibiting the CYP3A4 enzyme, thereby changing the blood concentration and increasing the risk of adverse reactions. In addition, foods containing high fat, high sugar or spicy food may aggravate gastrointestinal discomfort caused by drugs and should be avoided as much as possible.

Generally speaking, giritinib does not need to be taken strictly with food, but to improve tolerance and reduce gastrointestinal discomfort, you can choose to take it with or after a meal. At the same time, attention should be paid to avoid taking it with grapefruit and its products, and to maintain a light and balanced diet. During the medication period, patients should regularly monitor blood images, liver function and adverse reactions to ensure efficacy while reducing potential risks.

Reference materials:https://www.drugs.com/